Development of effective therapies against West Nile virus infection
- 1 December 2005
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 3 (6) , 931-944
- https://doi.org/10.1586/14787210.3.6.931
Abstract
Since its entry into North America in 1999, West Nile virus has spread throughout the USA and Canada, and now annually causes a clinical spectrum of human disease ranging from a self-limiting acute febrile illness to potentially lethal encephalitis. Although no therapy is currently approved for use in humans, several strategies are being pursued to develop effective prophylaxis and treatments. This review describes the epidemiology, clinical presentation and pathogenesis of West Nile virus infection, and highlights recent progress towards an effective therapy.Keywords
This publication has 99 references indexed in Scilit:
- Induction and suppression of RNA silencing: insights from viral infectionsNature Reviews Genetics, 2005
- Assembly and function of RNA silencing complexesNature Reviews Molecular Cell Biology, 2005
- A structural perspective of the flavivirus life cycleNature Reviews Microbiology, 2005
- Use of siRNAs to prevent and treat influenza virus infectionVirus Research, 2004
- RNA silencing in viral infections: insights from poliovirusVirus Research, 2004
- The Fusion Glycoprotein Shell of Semliki Forest VirusCell, 2001
- The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolutionNature, 1995
- A spring-loaded mechanism for the conformational change of influenza hemagglutininCell, 1993
- Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activitiesVirology, 1991
- Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virusArchiv für die gesamte Virusforschung, 1987